Who Paid My Doc
Ann Passini
Undersea and Hyperbaric Medicine Charleston, SC Doctor of Osteopathy
NPI 1578944476 CMS profile 1328022
316 Calhoun St, Charleston, SC 29401
General payments
$137
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Ann Passini of Charleston, SC is reported in the CMS Open Payments database as having received $137 across 5 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 23rd percentile of Undersea and Hyperbaric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $137 | 5 |
Beside peers
- Ann Passini
- Undersea and Hyperbaric Medicine median
- Middle half of Undersea and Hyperbaric Medicine
- National median
In program year 2025, general payments to Ann Passini were reported at $137. Among 121 Undersea and Hyperbaric Medicine profiles paid that year, the median was $208 and the middle half received between $52 and $518.
Show as a table
| Year | Ann Passini | Undersea and Hyperbaric Medicine median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $201 | $85–$538 | $163 |
| 2020 | $0 | $84 | $31–$222 | $114 |
| 2021 | $0 | $138 | $52–$383 | $132 |
| 2022 | $0 | $135 | $51–$385 | $149 |
| 2023 | $0 | $143 | $75–$442 | $160 |
| 2024 | $0 | $178 | $80–$442 | $164 |
| 2025 | $137 | $208 | $52–$518 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 78 drugsPart D claims
3,560
Drug cost
$258,779
Branded share of claims
15.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 59 | $77,095 | |
| Eliquis Apixaban | Brand | 38 | $46,955 | |
| Jardiance Empagliflozin | Brand | 25 | $32,815 | |
| Myrbetriq Mirabegron | Brand | 13 | $17,387 | |
| Incruse Ellipta Umeclidinium Bromide | Brand | 31 | $11,006 | |
| Trulicity Dulaglutide | Brand | 11 | $10,512 | |
| Januvia Sitagliptin Phosphate | Brand | 15 | $9,747 | |
| Xarelto Rivaroxaban | Brand | 11 | $8,324 | |
| Breo Ellipta Fluticasone/Vilanterol | Brand | 14 | $5,786 | |
| Arnuity Ellipta Fluticasone Furoate | Brand | 19 | $4,007 |
The 10 drugs with the highest cost, of 78 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 105,120 Part D prescribers listed as Family Practice; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 41 billing codesPaid by Medicare
$60,168
Medicare patients
144
Services billed
1,073
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 71% | |
| Arthritis | 50% | |
| Depression | 26% | |
| Chronic kidney disease | 24% | |
| Ischemic heart disease | 22% | |
| Osteoporosis | 21% | |
| Diabetes | 18% | |
| Atrial fibrillation | 17% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Sarscv2 vac 30mcg trs-suc im 91320 | Office | 16 | 17 | $2,549 |
| Vaccine for influenza for injection into muscle 90653 | Office | 21 | 21 | $1,718 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
5 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Undersea and Hyperbaric Medicine in South Carolina
Mary Hanley
Undersea and Hyperbaric Medicine · Charleston, SC
Jerod Lunsford
Undersea and Hyperbaric Medicine · Columbia, SC
Michael White
Undersea and Hyperbaric Medicine · Newberry, SC
David Cone
Undersea and Hyperbaric Medicine · Columbia, SC
Calvin Tran
Undersea and Hyperbaric Medicine · Goose Creek, SC
Related records
Undersea and Hyperbaric Medicine in South Carolina
Practitioners in the same specialty and state, ranked by reported value.
All Undersea and Hyperbaric Medicine
Everyone recorded under this specialty, nationwide.
Doctors in South Carolina
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.